首页> 美国卫生研究院文献>other >Evaluation of a novel multi-immunogen vaccine strategy for targeting 4E10/10E8 neutralizing epitopes on HIV-1 gp41 membrane proximal external region
【2h】

Evaluation of a novel multi-immunogen vaccine strategy for targeting 4E10/10E8 neutralizing epitopes on HIV-1 gp41 membrane proximal external region

机译:针对HIV-1 gp41膜近端外部区域上的4E10 / 10E8中和表位的新型多免疫原疫苗策略的评估

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The membrane proximal external region (MPER) of HIV-1 gp41 is targeted by broadly neutralizing antibodies (bnAbs) 4E10 and 10E8. In this proof-of-concept study, we evaluated a novel multi-immunogen vaccine strategy referred to as Incremental, Phased Antigenic Stimulation for Rapid Antibody Maturation (IPAS-RAM) to induce 4E10/10E8-like bnAbs. Rabbits were immunized sequentially, but in a phased manner, with three immunogens that are progressively more native (gp41-28×3, gp41-54CT, and rVV-gp160DH12). Although nAbs were not induced, epitope-mapping analyses indicated that IPAS-RAM vaccination was better able to target antibodies towards the 4E10/10E8 epitopes than homologous prime-boost immunization using gp41-28×3 alone. MPER-specific rabbit monoclonal antibodies were generated, including 9F6. Although it lacked neutralizing activity, the target epitope profile of 9F6 closely resembled those of 4E10 and 10E8 (671NWFDITNWLWYIK683). B-cell repertoire analyses suggested the importance of co-immunizations for maturation of 9F6, which warrants further evaluation of our IPAS-RAM vaccine strategy using an improved priming immunogen.
机译:HIV-1 gp41的膜近端外部区域(MPER)被广泛中和的抗体(bnAbs)4E10和10E8靶向。在此概念验证研究中,我们评估了一种新颖的多免疫原疫苗策略,称为快速抗体成熟的增量,分阶段抗原刺激(IPAS-RAM),以诱导4E10 / 10E8样bnAb。对兔子进行了连续免疫,但以分阶段的方式进行免疫,使用了三种免疫原,它们的天然性更高(gp41-28×3,gp41-54CT和rVV-gp160DH12)。尽管未诱导nAb,但表位作图分析表明,与单独使用gp41-28×3的同源初免-加强免疫相比,IPAS-RAM疫苗接种能够更好地将抗体靶向4E10 / 10E8表位。产生了MPER特异性的兔单克隆抗体,包括9F6。尽管它缺乏中和活性,但9F6的目标表位概况与4E10和10E8的相似( 671 NWFDITNWLWYIK 683 )。 B细胞库分析表明,共免疫对于9F6成熟非常重要,这有必要使用改进的启动免疫原进一步评估我们的IPAS-RAM疫苗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号